[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100211241":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":22,"centralContacts":26,"locations":32,"responsibleParty":48,"collaborators":10,"id":50,"slug":10,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":10,"eligibilityCriteria":54,"healthyVolunteers":55,"sex":56,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":10,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Kyungpook National University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Chorioretinal diseases",null,"chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.",[13],"Drug: Chorioretinal diseases",{"label":15,"type":10,"description":16,"interventionNames":10},"Control","control patients with surgeries include pars plana vitrectomy of macular hole, epiretinal membrane, cataract surgery.",[18],{"type":19,"name":9,"description":20,"armGroupLabels":21,"otherNames":10},"DRUG","chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration",[9],[23],{"name":24,"affiliation":5,"role":25},"Dong Ho Park, M.D","PRINCIPAL_INVESTIGATOR",[27],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"Dong Ho Park, M.D.","CONTACT","82-53-420-5813","sarasate2222@gmail.com",[33],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":10,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Dong Ho Park","RECRUITING","Daegu","Kyungsangpookdo","700-721","South Korea",{"type":41,"coordinates":42},"Point",[43,44],128.59111,35.87028,{"lat":44,"lon":43},[47],{"name":24,"role":29,"phone":30,"phoneExt":10,"email":31},{"type":25,"investigatorFullName":34,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Department of Opthalmology, School of medicine, Kyungpook National University","100211241",false,"NCT02026843","Analysis of Biomarkers From Patients With Chorioretinal Diseases","Inclusion Criteria:\n\n* age over 20 years\n* patients requiring ophthalmologic treatments for different degrees of decreasing of visual acuity.\n* patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.\n* control patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders.\n\nExclusion Criteria:\n\n* under the age of 20 years\n* patients that received any anti-vascular endothelial growth factor agent for proliferative disease before taking sample of aqueous humor\n* patients that did not signed the informed consent of the trial\n* patients with intraocular inflammations or infections that requiring any pharmaceutical agent\n* patients with recent ocular trauma",true,"ALL","20 Years","80 Years",{"count":60,"type":61},100,"ESTIMATED","OBSERVATIONAL","This study was conducted to investigate the levels of ocular biomarkers from the patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.",[65,66],"Diabetic Retinopathy","Macular Degeneration","2025-03-03",{"date":69,"type":70},"2025-03-06","ACTUAL",{"date":72,"type":10},"2012-04",{"date":74,"type":61},"2031-04",{"name":5,"class":6},1]